首页> CNS spectrums> Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE.

Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ibrahim,Turkoz

第一单位： Department of Statistics & Decision Sciences, Janssen Research & Development, LLC, Titusville, NJ, USA.

作者： Ibrahim,Turkoz ^[1] ; Oliver,Lopena ^[2] ; Giacomo,Salvadore ^[3] ; Gerard,Sanacora ^[4] ; Richard,Shelton ^[5] ; Dong-Jing,Fu ^[6]

作者单位： Department of Statistics & Decision Sciences, Janssen Research & Development, LLC, Titusville, NJ, USA. ^[1] Department of Neuroscience, Janssen Scientific Affairs, LLC, Titusville, NJ, USA. ^[2] Department of Neuroscience Experimental Medicine, Janssen Research & Development, LLC, Titusville, NJ, USA. ^[3] Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. ^[4] Department of Psychiatry, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. ^[5] Deparment of Neuroscience, Janssen Research & Development, LLC, Titusville, USA. ^[6]

关键词 Esketamine nasal spray esketamine major depressive disorder responder suicidality